Report Overview
Report Summary
Summary
Krabbe disease (KD) (also known as globoid cell leukodystrophy or galactosylceramide lipidosis) is a rare and often fatal lysosomal storage disease that results in progressive damage to the nervous system. KD involves dysfunctional metabolism of sphingolipids and is inherited in an autosomal recessive pattern.
Although there is no known cure for Krabbe disease, bone marrow transplantation has been shown to benefit cases early in the course of the disease. Generally, treatment for the disorder is symptomatic and supportive. Physical therapy may help maintain or increase muscle tone and circulation. Cord blood transplants have been successful in stopping the disease as long as they are given before overt symptoms appear.
In 2020, the global Krabbe Disease Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2027, with a CAGR of xx% between 2021 and 2027.
This report studies the Krabbe Disease Treatment market size by players, regions, product types and end industries, history data 2017-2020 and forecast data 2020-2027; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
This report focuses on the global top players, covered
GlaxoSmithKline
Johnson & Johnson
Novartis
...
Market segment by Regions/Countries, this report covers
North America
Europe
China
Rest of Asia Pacific
Central & South America
Middle East & Africa
Market segment by Type, the product can be split into
Anticonvulsants
Muscle Relaxants
HSCT
Others
Market segment by Application, the market can be split into
Hospitals
ASCs
The study objectives of this report are:
To study and forecast the market size of Krabbe Disease Treatment in global market.
To analyze the global key players, SWOT analysis, value and global market share for top players.
To define, describe and forecast the market by type, end use and region.
To analyze and compare the market status and forecast among global major regions.
To analyze the global key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Krabbe Disease Treatment are as follows:
History Year: 2017-2020
Base Year: 2020
Estimated Year: 2020
Forecast Year 2021 to 2027
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Raw material suppliers
Distributors/traders/wholesalers/suppliers
Regulatory bodies, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade associations and industry bodies
End-use industries
Available Customizations
With the given market data, EternityInsights offers customizations according to the company's specific needs. The following customization options are available for the report:
Further breakdown of Krabbe Disease Treatment market on basis of the key contributing countries.
Detailed analysis and profiling of additional market players.
Table Of Contents
Table Of Contents
Table of Contents
Krabbe Disease Treatment Market Report by Company, Regions, Types and Applications, Global Status and Forecast to 2025
1 Industry Overview of Krabbe Disease Treatment
1.1 Krabbe Disease Treatment Market Overview
1.1.1 Krabbe Disease Treatment Product Scope
1.1.2 Market Status and Outlook
1.2 Global Krabbe Disease Treatment Market Size and Analysis by Regions
1.2.1 North America
1.2.2 Europe
1.2.3 China
1.2.4 Rest of Asia Pacific
1.2.5 Central & South America
1.2.6 Middle East & Africa
1.3 Krabbe Disease Treatment Market by Type
1.3.1 Anticonvulsants
1.3.2 Muscle Relaxants
1.3.3 HSCT
1.3.4 Others
1.4 Krabbe Disease Treatment Market by End Users/Application
1.4.1 Hospitals
1.4.2 ASCs
2 Global Krabbe Disease Treatment Competition Analysis by Players
2.1 Krabbe Disease Treatment Market Size (Value) by Players (2018 and 2019)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future
3 Company (Top Players) Profiles
3.1 GlaxoSmithKline
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Krabbe Disease Treatment Revenue (Value) (2017-2020)
3.1.5 Recent Developments
3.2 Johnson & Johnson
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Krabbe Disease Treatment Revenue (Value) (2017-2020)
3.2.5 Recent Developments
3.3 Novartis
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Krabbe Disease Treatment Revenue (Value) (2017-2020)
3.3.5 Recent Developments
4 Global Krabbe Disease Treatment Market Size by Type and Application (2017-2020)
4.1 Global Krabbe Disease Treatment Market Size by Type (2017-2020)
4.2 Global Krabbe Disease Treatment Market Size by Application (2017-2020)
4.3 Potential Application of Krabbe Disease Treatment in Future
4.4 Top Consumer/End Users of Krabbe Disease Treatment
5 North America Krabbe Disease Treatment Development Status and Outlook
5.1 North America Krabbe Disease Treatment Market Size (2017-2020)
5.2 North America Krabbe Disease Treatment Market Size and Market Share by Players (2018 and 2019)
6 Europe Krabbe Disease Treatment Development Status and Outlook
6.1 Europe Krabbe Disease Treatment Market Size (2017-2020)
6.2 Europe Krabbe Disease Treatment Market Size and Market Share by Players (2018 and 2019)
7 China Krabbe Disease Treatment Development Status and Outlook
7.1 China Krabbe Disease Treatment Market Size (2017-2020)
7.2 China Krabbe Disease Treatment Market Size and Market Share by Players (2018 and 2019)
8 Rest of Asia Pacific Krabbe Disease Treatment Development Status and Outlook
8.1 Rest of Asia Pacific Krabbe Disease Treatment Market Size (2017-2020)
8.2 Rest of Asia Pacific Krabbe Disease Treatment Market Size and Market Share by Players (2018 and 2019)
9 Central & South America Krabbe Disease Treatment Development Status and Outlook
9.1 Central & South America Krabbe Disease Treatment Market Size (2017-2020)
9.2 Central & South America Krabbe Disease Treatment Market Size and Market Share by Players (2018 and 2019)
10 Middle East & Africa Krabbe Disease Treatment Development Status and Outlook
10.1 Middle East & Africa Krabbe Disease Treatment Market Size (2017-2020)
10.2 Middle East & Africa Krabbe Disease Treatment Market Size and Market Share by Players (2018 and 2019)
11 Market Forecast by Regions, Type and Application (2021-2027)
11.1 Global Krabbe Disease Treatment Market Size (Value) by Regions (2021-2027)
11.1.1 North America Krabbe Disease Treatment Revenue and Growth Rate (2021-2027)
11.1.2 Europe Krabbe Disease Treatment Revenue and Growth Rate (2021-2027)
11.1.3 China Krabbe Disease Treatment Revenue and Growth Rate (2021-2027)
11.1.4 Rest of Asia Pacific Krabbe Disease Treatment Revenue and Growth Rate (2021-2027)
11.1.5 Central & South America Krabbe Disease Treatment Revenue and Growth Rate (2021-2027)
11.1.6 Middle East & Africa Krabbe Disease Treatment Revenue and Growth Rate (2021-2027)
11.2 Global Krabbe Disease Treatment Market Size (Value) by Type (2021-2027)
11.3 Global Krabbe Disease Treatment Market Size by Application (2021-2027)
12 Krabbe Disease Treatment Market Dynamics
12.1 Krabbe Disease Treatment Market Opportunities
12.2 Krabbe Disease Treatment Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Krabbe Disease Treatment Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Krabbe Disease Treatment Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application
13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors
14 Research Finding/Conclusion
15 Appendix
Methodology
Analyst Introduction
Data Source